Online ISSN: 2515-8260

PITAVASTATIN AND GEMFIBROZIL AS DRUG REPOSITIONING CANDIDATES FOR ANXIOLYTIC ACTIVITY: AN ANIMAL STUDY BY USING ELEVATED PLUS MAZE

Main Article Content

Dr. Shoebul Haque,Dr. Ajit Mishra, Prof. Narendra Kumar,Dr. Shakita Fatima,Prof. Rishi Pal,Prof. Amod Kumar Sachan,. Prof. Rakesh Kumar Dixit

Abstract

Anxiety is a common finding in most neurotic disorders and plays a remarkable role in their pathogenesis. [1] Before the 20th century, “anxiety neurosis” and “pantophobia” terms were used to diagnose general anxiety. [2] In most anxiety cases, a person feels worsened episodes of symptoms followed by symptom-free episodes. This condition is referred to as “remitting and relapsing conditions.” [3] The exact cause of anxiety is still a topic of discussion; it may be due to inflection in the central nervous system. [4] Dyslipidemia is a solid soothsayer of persistent medical conditions like obesity that could elevate the risk of anxiety. [5] Several pathways, such as neurotransmitter balance, oxidative stress, and immuno-inflammatory processes associated with anxiety, are also connected with obesity.

Article Details